Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Nerve growth synthesis inducers produce neuroprotective effects

April 19, 1996

SKB reports calcium antagonists for stroke

April 19, 1996

New Takeda compounds suppress increased vascular permeability

April 19, 1996

Lilly reports cannabinoid receptor antagonists

April 19, 1996

Dolasetron submitted for approval in U.S.

April 19, 1996

Cerebyx approvable in USA

April 19, 1996

Myotrophin NDA submission on track

April 19, 1996

GP-3269, new AK inhibitor from Gensia

April 19, 1996

New dopamine D3 ligand from Warner-Lambert

April 19, 1996

P&U's U-99363E shows high affinity for D4 receptors

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...